Preparation and evaluation of inhalable dry powder containing glucosamine-conjugated gefitinib SLNs for lung cancer therapy-Reference-Cited by-同舟云学术

Preparation and evaluation of inhalable dry powder containing glucosamine-conjugated gefitinib SLNs for lung cancer therapy

Published:2020-07-13 Issue:8 Volume:46 Page:1265-1277
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Satari Nazafarin¹,Taymouri Somayeh¹^ORCID,Varshosaz Jaleh¹^ORCID,Rostami Mahboubeh²,Mirian Mina³

Affiliation:

1. Department of Pharmaceutics, School of Pharmacy and Novel Drug Delivery Systems Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran

2. Department of Medicinal Chemistry, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran

3. Department of Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2020.1788063

Reference51 articles.

1. Hyaluronic Acid Decorated Naringenin Nanoparticles: Appraisal of Chemopreventive and Curative Potential for Lung Cancer

2. Development and in vitro evaluation of core–shell type lipid–polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer

3. TPGS-Functionalized Polydopamine-Modified Mesoporous Silica as Drug Nanocarriers for Enhanced Lung Cancer Chemotherapy against Multidrug Resistance

4. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer harboring uncommon EGFR mutations: Focus on afatinib

5. A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhalable dry powder nano-formulations: advancing lung disease therapy-a review;Frontiers in Nanotechnology;2024-08-01

2. Nanoparticle-based targeted therapy through EGFR tyrosine kinase inhibitors and their recent advances in lung cancer therapy;Exploration of Medicine;2024-07-14

3. “Nano-in-Micro” Structured Dry Powder Inhalers for pulmonary delivery: Advances and challenges;Journal of Drug Delivery Science and Technology;2024-06

4. Spray-Dried Nanolipid Powders for Pulmonary Drug Delivery: A Comprehensive Mini Review;Pharmaceutics;2024-05-17

5. State-of-the-Art Review on Inhalable Lipid and Polymer Nanocarriers: Design and Development Perspectives;Pharmaceutics;2024-03-01